These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25667843)

  • 1. Sustained seizure remission on perampanel in progressive myoclonic epilepsy (Lafora disease).
    Schorlemmer K; Bauer S; Belke M; Hermsen A; Klein KM; Reif PS; Oertel WH; Kunz WS; Knake S; Rosenow F; Strzelczyk A
    Epilepsy Behav Case Rep; 2013; 1():118-21. PubMed ID: 25667843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perampanel Improves Cortical Myoclonus and Disability in Progressive Myoclonic Epilepsies: A Case Series and a Systematic Review of the Literature.
    Assenza G; Nocerino C; Tombini M; Di Gennaro G; D'Aniello A; Verrotti A; Marrelli A; Ricci L; Lanzone J; Di Lazzaro V; Bilo L; Coppola A
    Front Neurol; 2021; 12():630366. PubMed ID: 33841303
    [No Abstract]   [Full Text] [Related]  

  • 3. Perampanel as monotherapy and adjunctive therapy for focal onset seizures, focal to bilateral tonic-clonic seizures and as adjunctive therapy of generalized onset tonic-clonic seizures.
    Tyrlikova I; Brazdil M; Rektor I; Tyrlik M
    Expert Rev Neurother; 2019 Jan; 19(1):5-16. PubMed ID: 30560703
    [No Abstract]   [Full Text] [Related]  

  • 4. Retrospective study of perampanel efficacy and tolerability in myoclonic seizures.
    Gil-López FJ; Montoya J; Falip M; Aparicio J; López-González FJ; Toledano R; Gil-Nagel A; Molins A; García I; Serrano P; Domenech G; Torres F; Donaire A; Carreño M
    Acta Neurol Scand; 2018 Aug; 138(2):122-129. PubMed ID: 29573400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontal Hypoperfusion and the Effectiveness of Perampanel in Long-Lived Patient with Lafora Disease.
    Obara K; Abe E; Toyoshima I
    Case Rep Neurol; 2021; 13(1):211-217. PubMed ID: 33976658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study.
    Villanueva V; Montoya J; Castillo A; Mauri-Llerda JÁ; Giner P; López-González FJ; Piera A; Villanueva-Hernández P; Bertol V; Garcia-Escrivá A; Garcia-Peñas JJ; Garamendi I; Esteve-Belloch P; Baiges-Octavio JJ; Miró J; Falip M; Garcés M; Gómez A; Gil-López FJ; Carreño M; Rodriguez-Uranga JJ; Campos D; Bonet M; Querol R; Molins A; Tortosa D; Salas-Puig J
    Epilepsia; 2018 Sep; 59(9):1740-1752. PubMed ID: 30062784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of the efficacy of perampanel as treatment for myoclonic seizures and symptomatic myoclonus.
    Mir A; Alghamdi A; Alotaibi W; Samreen D; Alotaibi M; Albaradie R; Bashir S
    Epileptic Disord; 2022 Aug; 24(4):633-646. PubMed ID: 35770766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of perampanel in ten patients with Lafora disease.
    Goldsmith D; Minassian BA
    Epilepsy Behav; 2016 Sep; 62():132-5. PubMed ID: 27459034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seizure remission and improvement of neurological function in sialidosis with perampanel therapy.
    Hu SC; Hung KL; Chen HJ; Lee WT
    Epilepsy Behav Case Rep; 2018; 10():32-34. PubMed ID: 29977792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seizure control and improvement of neurological dysfunction in Lafora disease with perampanel.
    Dirani M; Nasreddine W; Abdulla F; Beydoun A
    Epilepsy Behav Case Rep; 2014; 2():164-6. PubMed ID: 25667898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of perampanel in children and adults with various epilepsy syndromes: A single-center postmarketing study.
    Singh K; Shah YD; Luciano D; Friedman D; Devinsky O; Kothare SV
    Epilepsy Behav; 2016 Aug; 61():41-45. PubMed ID: 27300147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Add-on perampanel in Lance-Adams syndrome.
    Steinhoff BJ; Bacher M; Kurth C; Staack AM; Kornmeier R
    Epilepsy Behav Case Rep; 2016; 6():28-9. PubMed ID: 27437182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perampanel: A Review in Drug-Resistant Epilepsy.
    Frampton JE
    Drugs; 2015 Sep; 75(14):1657-68. PubMed ID: 26370209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel deletion mutation in
    Orooj F; Umm-E-Kalsoom ; Zhao X; Ahmad A; Ahmed IN; Faheem M; Hassan MJ; Minasian BA
    Neurol Asia; 2021 Jun; 26(2):427-433. PubMed ID: 34733372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perampanel in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.
    Strzelczyk A; Willems LM; Willig S; Rosenow F; Bauer S
    Expert Rev Clin Pharmacol; 2015; 8(6):733-40. PubMed ID: 26436331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy of low-dose perampanel for progressive myoclonus epilepsy in a patient with Gaucher disease type 3.
    Tahara M; Higurashi N; Narita A; Ida H
    Brain Dev; 2022 Apr; 44(4):308-312. PubMed ID: 34991910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perampanel: Does it have broad-spectrum potential?
    Potschka H; Trinka E
    Epilepsia; 2019 Mar; 60 Suppl 1():22-36. PubMed ID: 29953584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of perampanel for partial-onset and primary generalized tonic-clonic seizures.
    Besag FM; Patsalos PN
    Neuropsychiatr Dis Treat; 2016; 12():1215-20. PubMed ID: 27274257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing Lafora body disease with vagal nerve stimulation.
    Mikati MA; Tabbara F
    Epileptic Disord; 2017 Mar; 19(1):82-86. PubMed ID: 28238966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.